Immediate Impact
1 by Nobel laureates 53 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Epigenetic modification of m6A regulator proteins in cancer
2023 Standout
Works of Rıdvan Ali being referenced
The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
2022
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rıdvan Ali | 337 | 125 | 208 | 161 | 51 | 577 | |
| Nicola Piccirillo | 321 | 179 | 174 | 81 | 67 | 690 | |
| Sabine Fürst | 580 | 184 | 190 | 73 | 45 | 714 | |
| Maria Luisa Moleti | 249 | 116 | 215 | 122 | 63 | 712 | |
| Mario Ojeda‐Uribe | 183 | 133 | 126 | 124 | 37 | 533 | |
| Tohru Sakura | 374 | 140 | 100 | 88 | 32 | 567 | |
| Carlo Castagnola | 320 | 185 | 88 | 126 | 47 | 558 | |
| Vaneuza Araújo Moreira Funke | 413 | 122 | 173 | 119 | 57 | 618 | |
| Daniel Coriu | 283 | 152 | 141 | 259 | 94 | 624 | |
| S H Advani | 256 | 140 | 158 | 134 | 50 | 600 | |
| Christoph Scheid | 353 | 92 | 148 | 143 | 37 | 554 |
All Works
Login with ORCID to disown or claim papers
Loading papers...